Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

73.60
+0.90001.24%
Volume:553.32K
Turnover:40.54M
Market Cap:14.18B
PE:-17.59
High:74.27
Open:74.02
Low:72.42
Close:72.70
52wk High:75.10
52wk Low:25.34
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.63
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.34
PE(LYR):-25.56

Loading ...

Aug 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Jul 02, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2025

Major Issues Report

Form 8-K - Current report
Jun 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report